Are GRCE insiders buying or selling?

Over the last 90 days, GRCE insiders were net buyers, reporting $774,472 of open-market purchases and $0.00 of sales.

When was the last GRCE insider purchase?

The most recent open-market purchase of Grace Therapeutics, Inc. stock by an insider was reported on Oct 26, 2026, one of 10 purchases in the last 90 days.

Where does GRCE insider trading data come from?

Watch Insiders reads the SEC Form 4 filings that Grace Therapeutics, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.

GRCESector not reported

Grace Therapeutics, Inc. (GRCE) Insider Trading

In the last 90 days, 2 Grace Therapeutics, Inc. (GRCE) insiders reported 10 open-market purchases totaling $774,472 and no sales. The most recent open-market purchase was reported on Oct 26, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers: 1
90-day purchase value: $774,472
Corporate buyers: 2
Latest transaction: Oct 26, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
Date	Insider name	Role	Type	Shares	Price	Total value
Oct 26, 2026	Opaleye Management Inc.	Corporate insider	Open Market Purchase	87,801	$1.81	$158,604
Oct 19, 2026	Opaleye Management Inc.	Corporate insider	Open Market Purchase	4,256	$1.88	$8,001
Oct 16, 2026	Opaleye Management Inc.	Corporate insider	Open Market Purchase	71,065	$1.92	$136,175
Oct 12, 2026	Opaleye Management Inc.	Corporate insider	Open Market Purchase	14,632	$2.03	$29,682
Oct 5, 2026	Opaleye Management Inc.	Corporate insider	Open Market Purchase	60,490	$2.05	$123,817
Sep 29, 2026	Opaleye Management Inc.	Corporate insider	Open Market Purchase	7,849	$2.09	$16,404
Sep 23, 2026	Opaleye Management Inc.	Corporate insider	Open Market Purchase	15,089	$2.10	$31,687
Sep 9, 2026	Opaleye Management Inc.	Corporate insider	Open Market Purchase	15,229	$2.09	$31,896
Sep 9, 2026	Prashant Kohli	Chief Executive Officer	Open Market Purchase	100,000	$2.14	$214,000
Aug 14, 2026	Opaleye Management Inc.	Corporate insider	Open Market Purchase	11,608	$2.09	$24,206

Common questions

GRCE insider trading FAQ

Are GRCE insiders buying or selling?: Over the last 90 days, GRCE insiders were net buyers, reporting $774,472 of open-market purchases and $0.00 of sales.
When was the last GRCE insider purchase?: The most recent open-market purchase of Grace Therapeutics, Inc. stock by an insider was reported on Oct 26, 2026, one of 10 purchases in the last 90 days.
Where does GRCE insider trading data come from?: Watch Insiders reads the SEC Form 4 filings that Grace Therapeutics, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.